Page last updated: 2024-09-04

cirsiliol and B16 Melanoma

cirsiliol has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bishayee, A; Hohmann, J; Prasad, P; Sinha, D; Vasas, A	1

Other Studies

1 other study(ies) available for cirsiliol and B16 Melanoma

Article	Year
Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway. International journal of molecular sciences, 2019, Jan-31, Volume: 20, Issue:3 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Flavones; Gene Expression Regulation, Neoplastic; Humans; Melanoma, Experimental; Mice; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Skin Neoplasms; Xenograft Model Antitumor Assays	2019

Article

Year

Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway.

International journal of molecular sciences, 2019, Jan-31, Volume: 20, Issue:3

Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Flavones; Gene Expression Regulation, Neoplastic; Humans; Melanoma, Experimental; Mice; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Skin Neoplasms; Xenograft Model Antitumor Assays

2019